Iovance Biotherapeutics, Inc.

NASDAQ:IOVA

Biotechnology

Healthcare
$7.48 -0.89%

-$0.04 today

Market cap
$3.46B
Beta
0.70
P/E (TTM)
-4.6
EPS (TTM)
-$0.85
52W Low $1.66High $5.63

Volume 6.99M

Average 14.09M

Balance Sheet

Inspect the capital base behind the business.

Assets

$913.17M

FY 2025 · Annual

+0.3% YoY

Liabilities

$214.59M

FY 2025 · Annual

+7.3% YoY

Equity

$698.58M

FY 2025 · Annual

-1.7% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents78.23M231.73M114.89M115.69M163.08M
Short-term Investments426.18M240.11M164.98M208.09M133.9M
Net Receivables00151K69.34M82.45M
Inventory0010.37M51.52M51.68M
Other Current Assets07.27M17.46M12.38M11.58M
Total Current Assets507.96M479.12M307.85M457.02M442.69M
Property, Plant & Equipment (Net)169.92M178.25M176.55M164.28M177.01M
Goodwill00000
Intangible Assets00229.26M282.4M279.32M
Long-term Investments91.59M066.43M00
Tax Assets00000
Other Non-current Assets7.87M6.62M270K6.73M14.15M
Total Non-current Assets269.38M184.87M472.5M453.41M470.48M
Total Assets777.33M663.98M780.35M910.43M913.17M
Account Payables27.38M26.6M33.12M27.51M22.16M
Short-term Debt00004.04M
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities0034.59M50.03M112.16M
Total Current Liabilities89.2M91.49M110.31M122.34M138.36M
Long-term Debt1M1M1M1M0
Deferred Tax Liabilities0017.35M32.32M31.83M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities66.47M72.86M85.43M77.68M76.23M
Total Liabilities155.67M164.34M195.74M200.02M214.59M
Common Stock7K8K11K13K17K
Retained Earnings(1.17B)(1.57B)(2.01B)(2.38B)(2.78B)
Accumulated OCI(601K)(902K)2.53M(1.05M)16.44M
Other Stockholders Equity00000
Minority Interest00000
Total Equity621.66M499.64M584.61M710.41M698.58M
Total Debt71.53M85.45M75.86M58.26M48.44M
Net Debt(6.7M)(146.29M)(39.03M)(57.43M)(114.63M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$57.9M
Short-term Investments$318.4M
Receivables$107.0M
Inventory$55.2M
Other Current$11.1M
Total Current Assets$549.6M
PP&E (Net)$171.9M
Intangible Assets$259.2M
Other Non-current$10.5M
Total Non-current Assets$441.6M
Total Assets$991.2M

Analysis

Selected assets total $991.2M for Latest. The largest visible component is Short-term Investments at $318.4M, about 32.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 13, 2026
4Statement of changes in beneficial ownershipNov 12, 2026
SC 13GSC 13G filingNov 10, 2026
4Statement of changes in beneficial ownershipNov 10, 2026
10-QQuarterly reportNov 5, 2026

How much cash does IOVA have?

Iovance Biotherapeutics, Inc. (IOVA) reported $163.08M in cash and equivalents in fiscal 2025.

How much debt does IOVA carry?

Iovance Biotherapeutics, Inc. (IOVA) reported $48.44M of total debt, with net debt of -$114.63M.